logo
Select company
Select metric
$ -1.79EBITDA per Share
VS
Market
13
Sector
33
Industry
45
History
89
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information

Ticker

RLAY

Company Name

RELAY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RELAY THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLAY - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -306.64M$ -1.791171.26M
3/31/2025$ -328.11M$ -1.941169.23M
12/31/2024$ -332.24M$ -2.331142.87M
9/30/2024$ -339.69M$ -2.421140.23M
6/30/2024$ -317.33M$ -2.391132.82M
3/31/2024$ -323.65M$ -2.471130.84M
12/31/2023$ -336.7M$ -2.751122.58M
9/30/2023$ -320.92M$ -2.631122.23M
6/30/2023$ -339.69M$ -2.791121.68M
3/31/2023$ -318.35M$ -2.621121.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, RELAY THERAPEUTICS INC's average EBITDAPS has been $ -2.43.
  • The median EBITDAPS for RELAY THERAPEUTICS INC during this period was $ -2.53
  • RELAY THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.73.
  • The lowest EBITDAPS recorded by RELAY THERAPEUTICS INC in the same timeframe $ -3.78

RELAY THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
TSHA : TAYSHA GENE THERAPIES INC $ -0.3DNTH : DIANTHUS THERAPEUTICS INC $ -3.19TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -10.84PRME : PRIME MEDICINE INC $ -1.42PGEN : PRECIGEN INC $ -0.41PRTA : PROTHENA CORP PUBLIC LTD CO $ -4.79ABSI : ABSCI CORP $ -0.78FATE : FATE THERAPEUTICS INC $ -1.31TVRD : TVARDI THERAPEUTICS INC $ -1.63PRAX : PRAXIS PRECISION MEDICINES INC $ -11.63

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for RELAY THERAPEUTICS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 71.25M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

RLAY - EBITDA per Share, Last 5 years

$ -3.78

Minimum

Dec 31, 2021

$ -0.73

Maximum

Mar 31, 2021

$ -2.43

Average

$ -2.53

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26